![]() |
Volumn 79, Issue 4, 2001, Pages 893-902
|
Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum
|
Author keywords
EAAC1; GLAST; GLT1; Levodopa therapy; Parkinson's disease; Striatum
|
Indexed keywords
BENSERAZIDE;
ENKEPHALIN;
GLUTAMATE TRANSPORTER;
GLUTAMATE TRANSPORTER EAAC1;
GLUTAMATE TRANSPORTER GLAST;
GLUTAMATE TRANSPORTER GLT1;
LEVODOPA;
MESSENGER RNA;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
OXIDOPAMINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CORPUS STRIATUM;
DENERVATION;
DRUG EFFECT;
FEMALE;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
NEUROTRANSMISSION;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PARKINSONISM;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
WESTERN BLOTTING;
AMINO ACID TRANSPORT SYSTEM X-AG;
ANIMALS;
CARRIER PROTEINS;
DENERVATION;
DOPAMINE;
DOPAMINE AGENTS;
ENKEPHALINS;
EXCITATORY AMINO ACID TRANSPORTER 1;
EXCITATORY AMINO ACID TRANSPORTER 2;
EXCITATORY AMINO ACID TRANSPORTER 3;
FEMALE;
FLUORESCENT ANTIBODY TECHNIQUE;
GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS;
LEVODOPA;
PROTEIN PRECURSORS;
RATS;
RNA, MESSENGER;
SUBSTANTIA NIGRA;
SYMPORTERS;
ANIMALIA;
|
EID: 0035191981
PISSN: 00223042
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1471-4159.2001.00644.x Document Type: Article |
Times cited : (32)
|
References (46)
|